|
C2ORF64 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
5.10830000521878E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.304800E-01 |
| Stage1-vs-Stage3 |
1.824350E-02 |
| Stage1-vs-Stage4 |
1.478640E-03 |
| Stage2-vs-Stage3 |
5.476200E-02 |
| Stage2-vs-Stage4 |
1.766450E-02 |
| Stage3-vs-Stage4 |
5.054000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
2.27919905171348E-11 |
| Normal-vs-Asian |
1.804820E-01 |
| Caucasian-vs-AfricanAmerican |
5.647400E-01 |
| Caucasian-vs-Asian |
5.675200E-01 |
| AfricanAmerican-vs-Asian |
6.580400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
6.900300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.95999891264387E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(81-100Yrs) |
3.54899999999159E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.382640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.936780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.089500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.752400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.427800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.948000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.262600E-03 |
| Normal-vs-Grade 2 |
5.55111512312578E-16 |
| Normal-vs-Grade 3 |
1.6242562850266E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
3.716000E-01 |
| Grade 1-vs-Grade 3 |
1.177960E-01 |
| Grade 1-vs-Grade 4 |
2.402700E-04 |
| Grade 2-vs-Grade 3 |
9.945600E-02 |
| Grade 2-vs-Grade 4 |
9.23730003599132E-09 |
| Grade 3-vs-Grade 4 |
2.03709999999635E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.98320249111816E-11 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
5.50004486399303E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62481139653892E-12 |
| Normal-vs-N1 |
1.80769998969765E-09 |
| N0-vs-N1 |
2.041900E-02 |
|
|
